# A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia

> **NCT01982071** · PHASE4 · TERMINATED · sponsor: **Astellas Pharma China, Inc.** · enrollment: 59 (actual)

## Conditions studied

- Candidemia
- Candidiasis

## Interventions

- **DRUG:** Micafungin

## Key facts

- **NCT ID:** NCT01982071
- **Lead sponsor:** Astellas Pharma China, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-09-26
- **Primary completion:** 2015-08-28
- **Final completion:** 2015-08-28
- **Target enrollment:** 59 (ACTUAL)
- **Why stopped:** Due to administrative reasons
- **Last updated:** 2024-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01982071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01982071, "A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01982071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*